The molecular profile of metastatic melanoma in Australia-Reference-Cited by-同舟云学术

The molecular profile of metastatic melanoma in Australia

Published:2016-02 Issue:2 Volume:48 Page:188-193
ISSN:0031-3025
Container-title:Pathology
language:en
Short-container-title:Pathology

Author:

Lyle Megan,Haydu Lauren E.,Menzies Alexander M.,Thompson John F.,Saw Robyn P.M.,Spillane Andrew J.,Kefford Richard F.,Mann Graham J.,Cooper Wendy A.,Yu Bing,Scolyer Richard A.,O'Toole Sandra A.,Long Georgina V.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference26 articles.

1. Mutations of the BRAF gene in human cancer;Davies;Nature,2002

2. Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma;Long;N Engl J Med,2014

3. Improved overall survival in melanoma with combined dabrafenib and trametinib;Robert;N Engl J Med,2015

4. Combined vemurafenib and cobimetinib in BRAF-mutated melanoma;Larkin;N Engl J Med,2014

5. A landscape of driver mutations in melanoma;Hodis;Cell,2012

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tissue-resident memory T cells in the era of (Neo) adjuvant melanoma management;Frontiers in Immunology;2022-11-16

2. Utility of next generation sequencing for differentiating malignant PEComa from metastatic melanoma;Pathology;2022-10

3. Pathologist initiated reflex BRAF mutation testing in metastatic melanoma: experience at a specialist melanoma treatment centre;Pathology;2022-08

4. Targeted Therapy for Melanomas Without BRAF V600 Mutations;Current Treatment Options in Oncology;2022-04-05

5. Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous Melanoma;Journal of Clinical Medicine;2022-02-04